SAS BIOPHARM LIMITEDActive
Key figures
Like most small UK companies, SAS BIOPHARM LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Total assets | 495,379 | 611,330 | 733,990 | 843,553 | 903,870 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 462,902 | 569,071 | 679,743 | 788,709 | 860,300 |
| Average number of employees | 1 | 1 | 0 | 0 | 1 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: SAS BIOPHARM LIMITED
Company
SAS BIOPHARM LIMITED is a private limited company registered with Companies House under company number 08640908. It was incorporated on 6 Aug 2013. Its status is active. The registered office is in London (NW11). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Aug 2025); the company files micro-entity accounts. Net assets were £860,300, up 9.1% on the previous year. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 May 2027. The next confirmation statement is due by 19 Aug 2027.